Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MADE-ITT: Valsartan vs HCTZ in Metabolic Syndrome
NCT00170937Phase 4Completed
- Sponsor
- Novartis
- Start
- Nov 2004
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valsartan, hydrochlorothiazide in hypertension (HTN), metabolic syndrome, sponsored by Novartis. Started Nov 2004; status: completed.
02
Drugs
valsartanhydrochlorothiazide
03
Conditions
hypertension (HTN)metabolic syndrome
Beyond the preview
Go deeper on NCT00170937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00170937.